REGENXBIO's (RGNX) CEO Ken Mills on Q2 2017 Results - Earnings Call Transcript

8/11/17

REGENXBIO Inc. (NASDAQ:RGNX)

Q2 2017 Earnings Conference Call

August 8, 2017 4:30 p.m. ET

Executives

Patrick Christmas - SVP and General Counsel

Ken Mills - President and CEO

Vit Vasista - CFO

Analysts

Matthew Harrison - Morgan Stanley

Operator

Good day, ladies and gentlemen, and welcome to the Q2 2017 REGENXBIO Inc. Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions]

I would now like to turn the call over to Patrick Christmas, Senior Vice President and General Counsel. Please go ahead.

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.

Connect with these Baltimore Professionals on LinkedIn

  • Edwin Warfield

    Editor in Chief, Warfield Digital

    Connect
  • Jean Halle

    Independent Consultant

    Connect
  • Larry Lichtenauer

    President of Lawrence Howard & Associates

    Connect
  • Newt Fowler

    Partner at Womble Carlyle, LLP

    Connect
  • David Crowley

    Owner at Develop DC

    Connect
  • Carolyn Stinson

    Stinson Marketing Group

    Connect